Atayan, YahyaCagin, Yasir FurkanErdogan, Mehmet AliHarputluoglu, Muhsin Murat MuhipBilgic, Yilmaz2024-08-042024-08-0420150001-56441477-4607https://hdl.handle.net/11616/967353,4-methylenedioxymethamphetamine (MDMA), an amphetamine derivative known as ecstasy, has stimulating and hallucinogenic properties. It has become a substance that is widely used especially by young people. Hepatotoxicity is one of the rare side effects of this substance and can be fatal. Ecstasy-induced fulminant hepatitis has been reported in case reports. The clinical course and the prognosis of the cases may differ. In this article, two cases in whom ecstasy-induced fulminant hepatic failure had developed and who were treated with liver transplantation, and one case which recovered with treatment, have been presented.eninfo:eu-repo/semantics/closedAccessacute hepatic failureexctasyArticle7815355261185782-s2.0-84926316479Q3WOS:000361654300009Q4